Deferred Tax Assets, Valuation Allowance of Traws Pharma, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Traws Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Traws Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $36,840,000, a 79% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Traws Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $36,840,000 -$137,451,000 -79% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $174,291,000 +$4,157,000 +2.4% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $170,134,000 -$3,720,000 -2.1% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $173,854,000 +$5,510,000 +3.3% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $168,344,000 +$7,319,000 +4.5% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q4 2019 $161,025,000 +$16,650,000 +12% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q4 2018 $144,375,000 $0 0% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $144,375,000 -$13,434,000 -8.5% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $157,809,000 +$8,738,000 +5.9% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q4 2015 $149,071,000 +$17,120,000 +13% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q4 2014 $131,951,000 +$38,647,000 +41% 31 Dec 2014 10-K 28 Mar 2016 2015 FY
Q4 2013 $93,304,000 +$38,007,000 +69% 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q4 2012 $55,297,000 31 Dec 2012 10-K 20 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.